These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 7847036

  • 1. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 2. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W, Muntean W.
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.
    Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H.
    Arch Intern Med; 1989 Jun; 149(6):1381-5. PubMed ID: 2499293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activated prothrombin complex concentrates in the management of the hemophiliac with Factor VIII inhibitor: case report.
    Griffen AL, Hoots WK, Carter AB.
    Pediatr Dent; 1987 Dec; 9(4):321-4. PubMed ID: 3148907
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y, Brouet JC.
    Nouv Presse Med; 1975 Oct 25; 4(36):2571-4. PubMed ID: 1081682
    [Abstract] [Full Text] [Related]

  • 11. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
    Prentice CR.
    Prog Clin Biol Res; 1984 Oct 25; 150():197-206. PubMed ID: 6431428
    [No Abstract] [Full Text] [Related]

  • 12. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C, Patharathienskul D, Suvatte V.
    Southeast Asian J Trop Med Public Health; 1993 Oct 25; 24 Suppl 1():106-12. PubMed ID: 7886549
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov 25; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 17. [Home treatment in hemophilia].
    Pabinger I, Niessner H, Korninger C, Nowotny C, Stain M, Kyrle PA, Lechner K.
    Wien Klin Wochenschr; 1987 Nov 20; 99(22):773-7. PubMed ID: 3124354
    [Abstract] [Full Text] [Related]

  • 18. Treatment of inhibitor patients with activated prothrombin complex concentrates.
    Penner JA.
    Prog Clin Biol Res; 1984 Nov 20; 150():291-308. PubMed ID: 6431434
    [Abstract] [Full Text] [Related]

  • 19. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S, Cattaneo M, Gervasoni W, Mannucci PM.
    Thromb Haemost; 1980 Oct 31; 44(2):72-5. PubMed ID: 6779400
    [Abstract] [Full Text] [Related]

  • 20. Treatment of anti-factor VIII antibodies.
    Blatt PM, White GC, McMillan CW, Roberts HR.
    Thromb Haemost; 1977 Aug 31; 38(2):514-23. PubMed ID: 579493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.